363 related articles for article (PubMed ID: 31108154)
1. The Biopharmaceutics Classification System (BCS) and the Biopharmaceutics Drug Disposition Classification System (BDDCS): Beyond guidelines.
Charalabidis A; Sfouni M; Bergström C; Macheras P
Int J Pharm; 2019 Jul; 566():264-281. PubMed ID: 31108154
[TBL] [Abstract][Full Text] [Related]
2. pH-Dependent solubility and permeability criteria for provisional biopharmaceutics classification (BCS and BDDCS) in early drug discovery.
Varma MV; Gardner I; Steyn SJ; Nkansah P; Rotter CJ; Whitney-Pickett C; Zhang H; Di L; Cram M; Fenner KS; El-Kattan AF
Mol Pharm; 2012 May; 9(5):1199-212. PubMed ID: 22489626
[TBL] [Abstract][Full Text] [Related]
3. Case studies for practical food effect assessments across BCS/BDDCS class compounds using in silico, in vitro, and preclinical in vivo data.
Heimbach T; Xia B; Lin TH; He H
AAPS J; 2013 Jan; 15(1):143-58. PubMed ID: 23139017
[TBL] [Abstract][Full Text] [Related]
4. A comparative analysis of biopharmaceutics classification system and biopharmaceutics drug disposition classification system: a cross-sectional survey with 500 bioequivalence studies.
Cristofoletti R; Chiann C; Dressman JB; Storpirtis S
J Pharm Sci; 2013 Sep; 102(9):3136-44. PubMed ID: 23580377
[TBL] [Abstract][Full Text] [Related]
5. Solubility-Permeability Interplay in Facilitating the Prediction of Drug Disposition Routes, Extent of Absorption, Food Effects, Brain Penetration and Drug Induced Liver Injury Potential.
Benet LZ
J Pharm Sci; 2023 Sep; 112(9):2326-2331. PubMed ID: 37429358
[TBL] [Abstract][Full Text] [Related]
6. Establishment of modified biopharmaceutics classification system absorption model for oral Traditional Chinese Medicine (Sanye Tablet).
Li H; Cao X; Liu Y; Liu T; Wang M; Ren X; Dou Z
J Ethnopharmacol; 2019 Nov; 244():112148. PubMed ID: 31400507
[TBL] [Abstract][Full Text] [Related]
7. State of the Art and Uses for the Biopharmaceutics Drug Disposition Classification System (BDDCS): New Additions, Revisions, and Citation References.
Bocci G; Oprea TI; Benet LZ
AAPS J; 2022 Feb; 24(2):37. PubMed ID: 35199251
[TBL] [Abstract][Full Text] [Related]
8. A reaction limited in vivo dissolution model for the study of drug absorption: Towards a new paradigm for the biopharmaceutic classification of drugs.
Macheras P; Iliadis A; Melagraki G
Eur J Pharm Sci; 2018 May; 117():98-106. PubMed ID: 29425862
[TBL] [Abstract][Full Text] [Related]
9. Reconciling Human-Canine Differences in Oral Bioavailability: Looking beyond the Biopharmaceutics Classification System.
Martinez MN; El-Kattan A; Awji E; Papich M
AAPS J; 2019 Aug; 21(5):99. PubMed ID: 31396733
[TBL] [Abstract][Full Text] [Related]
10. Is the full potential of the biopharmaceutics classification system reached?
Bergström CA; Andersson SB; Fagerberg JH; Ragnarsson G; Lindahl A
Eur J Pharm Sci; 2014 Jun; 57():224-31. PubMed ID: 24075971
[TBL] [Abstract][Full Text] [Related]
11. In vitro solubility, dissolution and permeability studies combined with semi-mechanistic modeling to investigate the intestinal absorption of desvenlafaxine from an immediate- and extended release formulation.
Franek F; Jarlfors A; Larsen F; Holm P; Steffansen B
Eur J Pharm Sci; 2015 Sep; 77():303-13. PubMed ID: 26091569
[TBL] [Abstract][Full Text] [Related]
12. Computational-Regulatory Developments in the Prediction of Oral Drug Absorption.
Valsami G; Macheras P
Mol Inform; 2011 Mar; 30(2-3):112-21. PubMed ID: 27466762
[TBL] [Abstract][Full Text] [Related]
13. Comparative Oral Drug Classification Systems: Acetazolamide, Azithromycin, Clopidogrel, and Efavirenz Case Studies.
Mora MJ; Onnainty R; Granero GE
Mol Pharm; 2018 Aug; 15(8):3187-3196. PubMed ID: 29927606
[TBL] [Abstract][Full Text] [Related]
14. The Biopharmaceutics Classification System: subclasses for in vivo predictive dissolution (IPD) methodology and IVIVC.
Tsume Y; Mudie DM; Langguth P; Amidon GE; Amidon GL
Eur J Pharm Sci; 2014 Jun; 57():152-63. PubMed ID: 24486482
[TBL] [Abstract][Full Text] [Related]
15. Predicting drug disposition via application of BCS: transport/absorption/ elimination interplay and development of a biopharmaceutics drug disposition classification system.
Wu CY; Benet LZ
Pharm Res; 2005 Jan; 22(1):11-23. PubMed ID: 15771225
[TBL] [Abstract][Full Text] [Related]
16. Evolution of Choice of Solubility and Dissolution Media After Two Decades of Biopharmaceutical Classification System.
Bou-Chacra N; Melo KJC; Morales IAC; Stippler ES; Kesisoglou F; Yazdanian M; Löbenberg R
AAPS J; 2017 Jul; 19(4):989-1001. PubMed ID: 28516359
[TBL] [Abstract][Full Text] [Related]
17. The role of BCS (biopharmaceutics classification system) and BDDCS (biopharmaceutics drug disposition classification system) in drug development.
Benet LZ
J Pharm Sci; 2013 Jan; 102(1):34-42. PubMed ID: 23147500
[TBL] [Abstract][Full Text] [Related]
18. BDDCS Predictions, Self-Correcting Aspects of BDDCS Assignments, BDDCS Assignment Corrections, and Classification for more than 175 Additional Drugs.
Hosey CM; Chan R; Benet LZ
AAPS J; 2016 Jan; 18(1):251-60. PubMed ID: 26589308
[TBL] [Abstract][Full Text] [Related]
19. The use of drug metabolism for prediction of intestinal permeability (dagger).
Chen ML; Yu L
Mol Pharm; 2009; 6(1):74-81. PubMed ID: 19132929
[TBL] [Abstract][Full Text] [Related]
20. The use of biopharmaceutic classification of drugs in drug discovery and development: current status and future extension.
Lennernäs H; Abrahamsson B
J Pharm Pharmacol; 2005 Mar; 57(3):273-85. PubMed ID: 15807982
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
